RxDoctor Payments Data

Christine Abt

Psychiatric/Mental Health, Community · Carol Stream, ILNPI 1073546016

Payments from drug & device makers

$2,343in general payments, 2019–2025

Across 140 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$550
  • Johnson & Johnson$303
  • Corium, LLC$281
  • Otsuka America Pharmaceutical, Inc.$220
  • Takeda Pharmaceuticals U.S.A., Inc.$129
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$102
  • plus $757 from 17 others

What the payments were for

  • Food & beverage$2,343100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few psychiatric/mental health, community providers in Illinoisto place this figure against a meaningful peer group, so we don't.

Where these figures come from

Is this you, or does something look wrong? →